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REVIEW
ACUTE KIDNEY INJURY CAUSED BY Crotalus AND Bothrops SNAKE VENOM: A REVIEW OF 
EPIDEMIOLOGY, CLINICAL MANIFESTATIONS AND TREATMENT
Polianna L.M.M. ALBUQUERQUE(1,2), Camilla N. JACINTO(2), Geraldo B. SILVA JUNIOR(2,3), Juliana B. LIMA(2),  
Maria do Socorro B. VERAS(1) & Elizabeth F. DAHER(2)
SUMMARY
Ophidic accidents are an important public health problem due to their incidence, morbidity and mortality. An increasing number of 
cases have been registered in Brazil in the last few years. Several studies point to the importance of knowing the clinical complications 
and adequate approach in these accidents. However, knowledge about the risk factors is not enough and there are an increasing number 
of deaths due to these accidents in Brazil. In this context, acute kidney injury (AKI) appears as one of the main causes of death and 
consequences for these victims, which are mainly young males working in rural areas. Snakes of the Bothrops and Crotalus genera 
are the main responsible for renal involvement in ophidic accidents in South America. The present study is a literature review of AKI 
caused by Bothrops and Crotalus snake venom regarding diverse characteristics, emphasizing the most appropriate therapeutic approach 
for these cases. Recent studies have been carried out searching for complementary therapies for the treatment of ophidic accidents, 
including the use of lipoic acid, simvastatin and allopurinol. Some plants, such as Apocynaceae, Lamiaceae and Rubiaceae seem to 
have a beneficial role in the treatment of this type of envenomation. Future studies will certainly find new therapeutic measures for 
ophidic accidents.
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INTRODUCTION
Snakes have evoked human curiosity since the ancient Egyptian 
civilizations and the book of Genesis shows the snake as the 
personification of Evil. In ancient Brazil, the lethal danger of ophidic 
accidents scared the Portuguese explorers. With the development of 
hyperimmune sera, a new phase in the study of ophidic accidents began, 
which is still of scientific interest to this day.
Ophidic accidents are still an important problem in public health 
due to their high frequency and severity3. There are approximately three 
thousand known snakes’ species and 20% are venomous34.
There are four clinically relevant venomous snakes’ genera in Latin 
America: Bothrops, Crotalus, Lachesis and Micrurus34. Snakes of the 
Bothrops genus are responsible for the majority of accidents, and this is 
partly due to their vast geographical distribution and aggressive behavior 
when feeling threatened38.
Due to its high vascularity, the kidney is highly susceptible to toxins44. 
The snakes of the genus Bothrops and Crotalus can cause severe systemic 
reactions, and acute kidney injury (AKI) is one of the most severe 
complications of snakebites2.
The knowledge of these complications by the health care professional 
is essential for an adequate approach of patients victims of accidents with 
venomous snakes. The aim of this study is to review the aspects of AKI 
caused by the venom of the Bothrops and Crotalus genera regarding their 
diverse characteristics, emphasizing the most appropriate therapeutic 
approach for these cases.
EPIDEMIOLOGICAL ASPECTS OF OPHIDIC ACCIDENTS
According to the World Health Organization (WHO), the presence 
of venomous snakes occurs in all the regions of the globe and is a 
public health problem, especially in tropical areas. Envenomation due 
to snakebites is considered one of the main neglected tropical diseases, 
affecting the poor rural populations of Africa, Asia, Latin America and 
Oceania22.
The WHO estimates the occurrence of 2,500,000 snakebites per 
year, resulting in 125,000 deaths worldwide and approximately 100,000 
survivors with severe consequences16,34. Latin America is the third most 
affected geographical area, after Africa and Asia5,16.
In Brazil, these accidents have shown a 32.7% increase in the period 
between 2004 and 2009, according to data from the Ministry of Health 
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(http://portal.saude.gov.br/portal/arquivos/pdf/clipping_30_07_2010.
pdf).
The epidemiological pattern of these accidents has remained 
unchanged for the last 100 years. The most affected individuals are young 
males (15-49 years), working in rural areas. The accidents occur mainly 
during the day, preferentially affecting the lower limbs, and most cases 
are caused by the Bothrops genus6. This pattern has been observed in 
many regions of Brazil9,25,31.
Regarding seasonality, the occurrence of ophidic accidents is, in 
general, related to weather factors and to increased human activity in 
rural areas. There is a higher incidence between the months of September 
and March in the South, Southeast and Midwest regions of Brazil, and 
between January and May in the Northeast region3. 
The sub-notification of these accidents in some regions of Brazil has 
been observed in some studies27,38. However, the Northeast region has 
registered an increase in the incidence of ophidic accidents in the last 
years, with an incidence similar to the that observed in other regions in 
2010 (15.5 accidents/100,000 inhabitants) (http://portal.saude.gov.br/
portal/arquivos/pdf/tabela_inc_casos_serpente_01_04_2011.pdf).
PATHOPHYSIOLOGY MECHANISMS OF ACUTE KIDNEY 
INJURY DUE TO SNAKEBITES
The renal manifestations of ophidic accidents have a broad clinical 
spectrum. Proteinuria, hematuria and renal failure are among the most 
common manifestations of snakebites42.
The pathophysiology of AKI due to snakebites has not been 
completely elucidated. Renal lesions can be caused by the isolated or 
combined action of different ischemic or nephrotoxic mechanisms, 
triggered by the venom action in the body3. Experimental studies suggest 
a multifactorial pathogenesis for this type of AKI, which includes the 
following mechanisms: renal ischemia resulting from hypovolemia and 
hypoperfusion, thrombotic microangiopathy due to the deposit of fibrin 
in the glomerular capillaries and direct cytotoxic action of the venom 
on the renal tubules23.
Proteinuria varies according to the snake species, and proteinuria 
levels > 1g/24h are not common24. Hematuria is frequently observed in 
accidents involving many snakes’ species, and can be microscopic or 
macroscopic. The outcome of hematuria is usually favorable. However 
it can be associated with acute tubular necrosis, which has a higher 
severity outcome42.
The occurrence of pigment nephropathy results from the action 
of the phospholipase A2 enzyme, which induces rhabdomyolysis42. 
BRAGA et al.11 demonstrated renal abnormalities after infusion of 
phospholipase A2 isolated from Bothrops insularis in Wistar rats. Some 
abnormalities observed in this study were related to increased perfusion 
pressure, renal vascular resistance, urinary flow and glomerular filtration 
rate, as well as decreased sodium and chloride transport. The proximal 
tubular cells showed hydropic alterations, evidenced by brush border 
discontinuity and desquamation to the tubular lumen, which can reflect 
the activity of phospholipase A2 and production of derivatives from 
arachidonic acid.
AKI is one of the main complications of ophidic accidents, which 
is described in all the types of snakes, being more common in accidents 
caused by the genus Bothrops and Crotalus in South America, and by 
the Vipera russelli in Asia, showing relevant morbimortality. AKI is the 
main cause of death among the victims of snakebites who survive the 
early effects of envenomation by Bothrops and Crotalus38. Although 
bothropic accidents are ten times more frequent than crotalic ones, the 
incidence of AKI is similar, which suggests a higher nephrotoxicity of 
the latter13,17,35,40.
PATHOPHYSIOLOGY OF RENAL LESION IN BOTHROPIC 
ACCIDENTS
The most commonly described anatomopathological lesion in 
bothropic accidents is acute tubular necrosis (ATN), but interstitial 
nephritis, cortical necrosis and glomerular changes have also been 
described34,38.
BURDMANN et al.13 demonstrated, in an experimental study, the 
morphological and functional changes induced by these accidents. 
There was a significant decrease in glomerular filtration rate and 
renal blood flow, as well as intravascular hemolysis, characterized 
by a decrease in hematocrit and increase in the levels of LDH and 
hemoglobin. Optic and electronic microscopy showed massive fibrin 
deposition in the glomerular capillaries, associated with proximal and 
distal tubular necrosis. These would be the main mechanisms involved 
in the genesis of AKI, although a direct effect of the venom on the 
kidney could not be ruled out.
Experimental studies with Bothrops moojeni venom have 
demonstrated glomerular injury, tubular degeneration and desquamation, 
hematuria and decrease in glomerular filtration rate, with increased 
urinary sodium excretion, no alteration in arterial blood pressure and 
no fibrin deposit in the glomerular capillaries7. Other studies have 
demonstrated a direct effect of the bothropic venom on the kidneys, 
leading to tubular and glomerular injury8,14,30.
A series of variables seem to be involved in the development of AKI 
after ophidic accidents: patients’ age and body surface area, snake’s 
age, amount of inoculated venom, area of the bite and time between 
the accident and administration of specific anti-venom sera. Associated 
comorbidities, such as hypertension, diabetes, coronary artery disease 
and previous nephropathies, can also make the patients more susceptible 
to the venom effects18.
The prevalence of AKI induced by bothropic accidents varies between 
1.4 and 38%, depending on the species involved12,33,38. Mortality varies 
from 13 to 19%34. Peak AKI incidence varies from a few hours after 
the accident to 96 h after the snakebite and is commonly diagnosed in 
the first 24-48 h. Need of dialysis varies from 33 to 75% of cases3,36,45. 
PATHOPHYSIOLOGY OF KIDNEY INJURY IN  
CROTALIC ACCIDENTS
Diverse mechanisms have been proposed to explain the kidney 
injury caused by crotalic venom, including rhabdomyolysis, hemolysis, 
shock, intravascular coagulation and a possible direct nephrotoxic 
effect18.
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As the venom is excreted by the kidneys, the mechanisms of 
concentration and tubular transport favor the occurrence of direct 
cellular toxicity36. Crotalic venom is a complex mix of enzymes, toxins 
and peptides, with crotoxin being one of the main responsible for the 
nephrotoxicity.
MONTEIRO et al.29 demonstrated that crotoxin causes systemic 
lesions and skeletal muscle injury. Crotoxin was the main responsible 
for acute nephrotoxicity in isolated kidneys of rats, being associated with 
glomerular and tubular changes.
CLINICAL MANIFESTATIONS
Snake venom consists of more than 20 different substances, of 
which effects have not yet been completely studied. The protein fraction 
(enzymes, non-enzymatic toxins and non-toxic proteins) comprises 90-
95% of its weight38.
The bothropic venom, despite the variability of its composition 
between species from different regions and within the same species, 
depending on the snake’s age, in general, shows a mechanism 
characterized by proteolytic, coagulant and hemorrhagic action, leading 
to local and systemic characteristic manifestations38. The action of 
proteases, hyaluronidases, phospholipases and inflammatory mediators 
leads to local tissue injury, with early onset of pain, edema, bleeding 
and bullous lesions, which can complicate with abscesses and tissue 
necrosis. Among the systemic manifestations, hemorrhagic events 
(epistaxis, gingivorrhagia, hematuria, hemoptysis, central nervous 
system bleeding) are associated to coagulation disturbances secondary 
to the activation of factor X and to an action similar to that of thrombin, 
leading to coagulation factor consumption, as it occurs during the process 
of intravascular coagulation3,22.
Neurotoxicity and myotoxicity are other typically reported 
consequences, especially in the crotalic accidents. The first is caused by 
the action of crotoxin, a neurotoxin that comprises 50% of the protein 
fraction of crotalic venom and acts in the pre-synaptic membrane 
of the neuromuscular junction, leading to a descending progressive 
paralysis, which can be fatal when involving the bulbar and respiratory 
musculature18. In turn, the myotoxic action leads to rhabdomyolysis, 
which can result in myoglobinemia, hyperkalemia and AKI. Hypotension 
and shock are other possible complications that have been described23,34.
According to the clinical manifestations, the ophidic accident can be 
classified as mild, moderate or severe, which is important to guide the 
therapeutic measures to be adopted. The severity of these accidents is 
based on local manifestations (presence of pain, edema and ecchymosis), 
systemic manifestations (hemorrhage, shock, anuria), coagulation time and 
time to administrate the antiophidic sera. Severe cases are considered when 
there are intense local manifestations, severe hemorrhage/shock/anuria, 
abnormal coagulation time and need for a higher dose of anti-ophidic sera3.
The specific treatment consists in the administration of anti-ophidic 
sera, produced from the sensitization of diverse animals, especially 
equines. In Brazil, the Butantan Institute (São Paulo), Ezequiel Dias 
Foundation (Minas Gerais) and Vital Brazil Institute (Rio de Janeiro) 
are responsible for the production of these immune derivatives for the 
public health system.
Recently, Brazilian researchers evaluated the neutralizing action of 
the extract from a native plant against the toxic activity of the bothropic 
venom in rats. Schizolobium parahyba, popularly known as “guapuruvu” 
and commonly used in the central region of the country to treat snakebites, 
was effective to protect against the effects induced by the enzymatic 
and biological action of the venom of some species from the Bothrops 
genus, constituting a promising sustainable therapeutic option for these 
accidents38. 
SNAKEBITE-INDUCED ACUTE KIDNEY INJURY 
APPROACH
Throughout history, the treatment of ophidic accidents varied from 
surgical excisions to topical therapy46. The recommendations have 
changed with time and the anti-ophidic sera has been used with increasing 
frequency. The use of tourniquets was indicated in the past, in order to 
isolate the injured member in an attempt to decrease venom dissemination 
in the body, but it is no longer indicated due to its inefficiency.
In kidney injuries caused by animal toxins, AKI secondary to renal 
ischemia is the most common type43. Multiple factors contribute to this 
fact, such as hemodynamic changes, inflammatory reactions and direct 
nephrotoxic effect of the venom (Fig. 1)44. The knowledge of these factors 
is of huge importance as it provides subsidies to an effective therapy.
The first action to be undertaken when treating a snakebite victim 
is to soothe the patient, as the hyperdynamic state accelerates venom 
dissemination1. The patient should be placed in a comfortable position, 
with the affected limb elevated at the heart’s level1.
To better detail the AKI approach, we divided it in support measures 
(initial approach), classical measures for AKI and specific measures.
The supportive measures includes: hypovolemia correction; broad 
spectrum antibiotics administration in severe bite cases (for instance, 
clindamycin and ceftriaxone; ciprofloxacin and clindamycin; ampicillin/
sulbactam); tetanus prophylaxis; monitoring of the local edema evolution; 
careful assessment of the response to specific antivenom therapy; early 
Fig. 1 - Pathophysiology of kidney injury induced by animal toxins. Adapted from SITPRIJA 
et al.
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detection of local and systemic complications; surgical procedures and 
rehabilitation (in severe cases of local complications)32.
Early treatment of hypovolemia is a fundamental measure for AKI 
prevention. The use of isotonic solutions (Ringer’s lactate or saline) 
is required to restore circulating volume32. Urinary volume should be 
measured every hour, mainly in severe cases. Normally, adolescents and 
adults have a urinary volume higher than 0.5 mL/kg/h (30-40 mL/h) and 
children higher than 1.0 to 2.0 mL/kg/h.
Antibiotic use is controversial, as there have been few clinical trials 
and there are different snakes’ species with different potentials to cause 
infection32. However, biological samples should be collected for culture 
performance in order to provide the identification of any agent causing 
infection and the correspondent antimicrobial sensitivity pattern32. 
According to AMARAL et al.3, the use of antibiotics should be indicated 
when there is evidence of infection. The bacteria isolated from lesions 
secondary to snakebites are mainly Morganella morganii, Escherichia 
coli, Providencia sp and Streptococcus group D.
Monitoring of local edema evolution and bleeding should be 
performed every hour in the first day and every 6 hours thereafter32.
The therapeutic approach to AKI induced by ophidic accidents is 
summarized in Table 1.
Attention should also be paid to the systemic signs of severity, 
including persistent bleeding, neurological symptoms (ptosis, 
paresthesia, visual abnormalities, vertigo, etc.), cardiovascular 
abnormalities (hypotension, arrhythmia, shock) and kidney injury (AKI, 
hemoglobinuria, myoglobinuria, etc.)21. Among the local complications, 
compartment syndrome is clinically suspected in the presence of tense 
edema, dysesthesia, proprioception alteration and movement limitation, 
with or without decreased capillary refill time. Prompt intervention 
is required in these cases, through the administration of intravenous 
mannitol or surgery (fasciotomy)32. 
The use of intramuscular injections (such as antitetanic vaccine) 
should be avoided in the first 48 hours after the accident or when there 
is coagulopathy persistence32.
The classical measures for AKI include fluid correction and 
electrolyte management, judicious use of diuretics and vasoactive drugs26.
The adequate volemic status is the main measure for AKI prevention 
and is also indicated to treat AKI. There are no specific guidelines for 
hemodynamic optimization and renal function preservation; however, one 
can extrapolate the recommendations from other causes of AKI to that 
caused by snakebites26. It is important to be careful when administrating 
fluids to patients with comorbidities, such as heart and liver disease, in 
order to avoid fluid overload and its complications. 
The use of diuretics in AKI treatment is controversial. MACEDO et 
al.26 suggest that it is possible to try to increase urinary volume with loop 
diuretics, but if there is no adequate response, increasing doses should be 
avoided. Regarding the use of natriuretics, large studies are required to 
confirm its benefit in AKI treatment26. Vasoactive agents are considered 
in the cases with organ perfusion impairment and the use of dopamine 
in order to prevent or treat AKI is not recommended26.
The complications associated to AKI (acute pulmonary edema, 
electrolyte and acid-base disturbances) that are refractory to clinical 
treatment should be promptly treated with renal replacement therapy. 
The need for dialysis in victims of ophidic accidents has been described 
by SITPRIJA et al.41, and this treatment also improves myalgia 
symptoms.
Regarding specific measures, the anti-ophidic sera (immunoglobulin, 
antivenom) is the only specific treatment for snakebites. The sera 
are produced by fractioning plasma obtained from domestic animals 
hyper-immunized against the venoms. When administered to humans, it 
neutralizes the venom responsible for the accident, and, in some cases, 
it also neutralizes venoms from related species47. It is very important to 
have in mind that the early administration of anti-ophidic sera is one of 
the most effective measures to prevent AKI induced by Bothrops and 
Crotalus accidents.
The identification of the snake and the classification of accident 
severity are the first steps for the correct prescription of anti-ophidic 
sera. Another important step is the anaphylaxis surveillance during its 
administration, as this is an heterologous immunoglobulin.
In cases of envenomation by Bothrops sp., the administration of 
antibothropic serum (ABS) should be instituted as early as possible, and 
when it is not available, the anticrotalic (ACS) or antibothropic- lachesis 
(ABLS) serum should be administered3. 
If the coagulation time remains unchanged 24 hours after serum 
therapy, an additional dose is indicated, with two ampoules of antivenom 
sera3.
Some laboratory tests are important in bothropic accidents, including 
time of coagulation, complete blood count (it can reveal leukocytosis with 
neutrophilia and thrombocytopenia), urinalysis (to screen for proteinuria, 
hematuria and leukocyturia) and other tests according to the patient’s 
Table 1
Therapeutic approach to acute kidney injury caused by ophidic accidents
Supportive measures (Initial 
approach)
Hypovolemia correction, adminis-
tration of large-spectrum antibiot-
ics in moderate to severe cases, 
tetanus prophylaxis, surveillance of 
the response to specific antivenom 
therapy, early detection of local and 
systemic complications, surgical 
procedures and rehabilitation (in 
severe cases of local complications)
Classic measures for AKI Correct approach of fluid and elec-
trolyte disturbances, use of diuret-
ics and vasoactive drugs (when 
indicated) 
Specific measures Antiophidic sera (immunoglobulin, 
antivenom) is the only specific treat-
ment for envenomation by snake-
bites.
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evolution, with special attention to electrolytes, urea and creatinine to 
detect AKI3.
In crotalic accidents, the dose of anticrotalic sera varies according 
to the severity of the case. It is important to note that the same dose is 
administered to adults and children, and the ACS sera can also be used3, 
according to what is shown in Table 2.
As the crotalic toxin has myotoxic, neurotoxic and coagulant actions, 
rhabdomyolysis is an important factor in AKI genesis in these accidents. 
According to BOSCH et al.10, preventive and therapeutic measures for 
rhabdomyolysis-induced AKI includes: (1) monitoring of volemic status, 
central venous pressure and urinary volume, (2) evaluation of serum levels 
of creatine kinase (CK), myoglobin, aldolase, lactate-dehydrogenase, 
alanine aminotransferase, aspartate aminotransferase, (3) monitoring of 
levels of urea, creatinine, sodium, potassium, total and ionized calcium, 
phosphorus, magnesium, uric acid, albumin, platelet count, white and red 
blood cell count, (4) evaluation of urine sediment and dipstick, (5) volemic 
restoration with isotonic saline solution, at a rate of approximately 
400 mL/h, monitoring of central venous pressure, (6) obtaining a urinary 
output of 3 mL/kg/h, (7) frequent monitoring of potassium levels, 
(8) correction of hypocalcemia only if it is symptomatic or if there is 
severe hypercalcemia, (9) if the urine pH is below 6.5, alternate each 
liter of saline solution with dextrose or 0.45% solution with 100 mmoL 
bicarbonate, (10) consider treatment with mannitol, discontinuing it if there 
is improvement in diuresis (> 20 mL/h); if it does not occur, (11) maintain 
volemic infusion until myoglobinuria decreases and (12) consider renal 
replacement therapy if there is no response to therapy or if there is persistent 
hyperkalemia (> 6.5 mEq/L), oliguria (< 0.5 mL/kg/h, in 12 hours), anuria, 
hypervolemia and refractory metabolic acidosis. 
The knowledge of early and late reactions to the administration 
of anti-ophidic sera and its correct treatment is important to prevent 
fatal complications. The adverse effects of anti-ophidic sera are: type 
I acute reactions, due to reactions of circulating immunoglobulin E 
to horse proteins; anaphylactoid reactions due to direct degranulation 
of mastocytes and serum sickness (a late allergic reaction caused by 
immune complexes)1.
The early reactions occur in 4.6 to 87.2% of cases in the first two 
hours after serum administration. They have low severity and the patient 
should be under observation for 24 hours due to the risk of onset of 
more severe late reactions3. Signs and symptoms include urticarial rash, 
tremors, coughing, nausea, abdominal pain, pruritus and facial rash. 
More severe manifestations, such as anaphylactic reactions, are rare. In 
these cases, the patients can also have arrhythmias, hypotension, shock 
and respiratory failure3.
The late reactions occur five to 24 days after serum administration 
and can cause fever, arthralgia, lymphadenomegaly, urticarial rash and 
proteinuria. The incidence of serum sickness is underestimated, as many 
patients do not return to the health care center. The use of corticosteroids 
(prednisone) 1 mg/kg/day (maximum 60 mg) for five to seven days3 is 
indicated for the treatment of this complication.
The use of intravenous corticosteroids, promethazine and adrenaline 
can be therapeutic for anaphylactic reactions to heterologous sera. As 
premedication such as H2-antagonists, such as cimetidine (maximum 300 
mg) or ranitidine3 can also be used. SILVA et al.39 demonstrated, in a 
randomized study with 752 patients with acute reactions to heterologous 
sera in the first 48 hours, that the use of subcutaneous adrenalin decreased 
the risk of severe adverse reactions in the first hour; however, neither 
hydrocortisone nor promethazine showed clear benefits.
The therapeutic measures are of huge importance in the management 
of victims of ophidic accidents and the early administration is 
fundamental to prevent AKI occurrence. CASTRO et al.14, in an 
experimental study with bothropic venom, showed that the ideal renal 
protection was obtained when the administration of the venom and 
the sera were performed at the same time. In a prospective study with 
100 victims of crotalic accidents, it was demonstrated that the delay in 
the administration of antiophidic sera (> 2h) was an independent risk 
factor for AKI development33.
FUTURE PERSPECTIVES
Some studies have searched for complementary therapies for 
the treatment of ophidic accidents. BARONE et al.4, through an 
experimental study using Bothrops jararaca venom in AKI induction in 
rats, demonstrated the beneficial effects of lipoic acid and simvastatin 
Table 2
Classification of crotalic accidents regarding severity and recommended specific therapy
Manifestations and treatment
Classification - Initial evaluation
Mild Moderate Severe
Myasthenic fascies and blurred vision Absent or late Mild or evident Evident
Myalgia Absent or mild Mild Intense
Coagulation time (CT) Normal or altered Normal or altered Normal or altered
Red or brown urine Absent Poor evident or absent Present
Oliguria or anuria Absent Absent Present or absent
Serum therapy (# ampoules) ABS/ABCS* 5 10 20
Administration via Intravenous
* ABS = anti-bothropic serum/ABCS = anti-bothropic - crotalic serum.
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on hyperuricemia, renal oxidative stress and serum levels of urea and 
creatinine, creating new perspectives for the investigation of these drugs 
as adjuvant agents in bothropic envenomation therapy.
An experimental study with rats with AKI induced by Crotalus 
durissus terrificus envenomation evidenced the association between 
hyperuricemia and kidney injury in these animals, as well as the beneficial 
effect of allopurinol on renal function recovery, preventing death in 
these animals 20.
MOLANDER et al.28 created a database of plants used in ophidic 
accidents in the world, selecting countries from different continents 
(Brazil, Nicaragua, China and Nepal). The most common plants were 
those from the families Apocynaceae, Lamiaceae and Rubiaceae. It was 
observed that the use of the same plant in different regions and further 
studies are required to better investigate the role of these plants in the 
treatment of snakebite envenomation.
SAUL et al.37, upon considering that the snakes’ toxins first reach 
the lymph nodes before entering circulation, studied the use of a nitric 
oxide ointment in 15 patients and obtained satisfactory results regarding 
the inhibition of lymphatic transport of the toxin.
All these studies can be used as a base for the development of new 
research in ophidic accidents and its complications.
RESUMO
Lesão renal aguda causada pelo veneno das cobras Crotalus e 
Bothrops: revisão da epidemiologia, das manifestações clínicas e 
do tratamento
Os acidentes ofídicos são importante problema de saúde pública 
devido à incidência, morbidade e mortalidade. Aumento do número de 
casos tem sido registrado no Brasil nos últimos anos. Vários estudos 
apontam para a importância do conhecimento das complicações clínicas 
e do tratamento adequado desses acidentes. Entretanto o conhecimento 
dos fatores de risco não é suficiente, e existe número crescente de óbitos 
devido a esses acidentes no Brasil. Neste contexto, a injúria renal aguda 
(IRA) aparece como uma das principais causas de óbito e sequela 
nestas vítimas, que são principalmente homens trabalhadores de zonas 
rurais. Os gêneros Bothrops e Crotalus são os principais responsáveis 
pelo envolvimento renal nos acidentes ofídicos na América do Sul. O 
presente estudo faz uma revisão da literatura sobre a IRA causada pela 
picada das serpentes dos gêneros Bothrops e Crotalus em suas diversas 
características, enfatizando a abordagem terapêutica mais adequada 
para estes casos. Estudos recentes tem sido realizados para a busca 
de terapias complementares para o tratamento dos acidentes ofídicos, 
incluindo o uso de ácido lipóico, sinvastatina e alopurinol. Algumas 
plantas, como a Apocynaceae, Lamiaceae e Rubiaceae parecem ter 
papel benéfico no tratamento destes envenenamentos. Estudos futuros 
irão certamente encontrar novas estratégias terapêuticas para os 
acidentes ofídicos.
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